Literature DB >> 9112237

The interaction of C-reactive protein and serum amyloid P component with nuclear antigens.

T W Du Clos1.   

Abstract

The pentraxins are a family of proteins characterized by cyclic pentameric structure, calcium-dependent ligand binding and sequence homology. The two main representatives of this family are the serum proteins, C-reactive protein (CRP) and serum amyloid P component (SAP). In man CRP is an acute phase reactant which increases up to 1,000 fold during the acute phase response whereas SAP is a constitutive protein expressed at about 30 micrograms/ml. These proteins activate complement through the classical pathway and participate in opsonization of particulate antigens and bacteria. In the past several years it has been determined that both of these pentraxins interact with nuclear antigens including chromatin and small nuclear ribonucleoproteins (snRNPs). Both CRP and SAP have nuclear transport signals which facilitate their entry into the nuclei of intact cells. Furthermore, these pentraxins have been shown to affect the clearance of nuclear antigens in vivo. It is now believed that one of the major functions of the pentraxins could be to interact with the nuclear antigens released from apoptotic or necrotic cells. This interaction could mitigate against deposition of these antigens in tissue and autoimmune reactivity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9112237     DOI: 10.1007/bf00351177

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  40 in total

1.  The effect of acute phase proteins on clearance of chromatin from the circulation of normal mice.

Authors:  R W Burlingame; M A Volzer; J Harris; T W Du Clos
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

2.  Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins).

Authors:  A P Osmand; B Friedenson; H Gewurz; R H Painter; T Hofmann; E Shelton
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

Review 3.  Murine models of systemic lupus erythematosus.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1985       Impact factor: 3.543

4.  Analysis of the binding of C-reactive protein to histones and chromatin.

Authors:  T W Du Clos; L T Zlock; R L Rubin
Journal:  J Immunol       Date:  1988-12-15       Impact factor: 5.422

5.  Identification of a polypeptide sequence that mediates nuclear localization of the acute phase protein C-reactive protein.

Authors:  T W Du Clos; C Mold; R F Stump
Journal:  J Immunol       Date:  1990-12-01       Impact factor: 5.422

6.  Binding of fibronectin by the acute phase reactant C-reactive protein.

Authors:  E M Salonen; T Vartio; K Hedman; A Vaheri
Journal:  J Biol Chem       Date:  1984-02-10       Impact factor: 5.157

7.  Kinetics and mechanisms for removal of circulating single-stranded DNA in mice.

Authors:  W Emlen; M Mannik
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

8.  Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.

Authors:  C Mohan; S Adams; V Stanik; S K Datta
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

9.  Clearance of circulating DNA-anti-DNA immune complexes in mice.

Authors:  W Emlen; M Mannik
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

10.  C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro.

Authors:  F A Robey; K D Jones; A D Steinberg
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

View more
  25 in total

Review 1.  Defects in the disposal of dying cells lead to autoimmunity.

Authors:  Udo S Gaipl; Sandra Franz; Reinhard E Voll; Ahmed Sheriff; Joachim R Kalden; Martin Herrmann
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

2.  Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus.

Authors:  A E M van Nieuwenhuijze; T van Lopik; R J T Smeenk; L A Aarden
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

3.  Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.

Authors:  G Zandman-Goddard; M Blank; P Langevitz; L Slutsky; M Pras; Y Levy; O Shovman; T Witte; A Doria; J Rovensky; Y Shoenfeld
Journal:  Ann Rheum Dis       Date:  2005-07-13       Impact factor: 19.103

4.  SAP suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.

Authors:  Zhe Ji; Zun-Ji Ke; Jian-Guo Geng
Journal:  Immunol Cell Biol       Date:  2011-06-07       Impact factor: 5.126

Review 5.  C-reactive protein, inflammation, and innate immunity.

Authors:  R F Mortensen
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

6.  Absence of FcγRIII results in increased proinflammatory response in FcγRIII-KO cardiac recipients.

Authors:  Melek M Erdinc Sunay; Karen Fox-Talbot; Ergun Velidedeoglu; William M Baldwin; Barbara A Wasowska
Journal:  Transplantation       Date:  2013-10-15       Impact factor: 4.939

Review 7.  Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors.

Authors:  Terry W Du Clos; Carolyn Mold
Journal:  Curr Opin Organ Transplant       Date:  2011-02       Impact factor: 2.640

8.  Dietary modulation and structure prediction of rat mucosal pentraxin (Mptx) protein and loss of function in humans.

Authors:  Cindy van der Meer-van Kraaij; Roland Siezen; Evelien Kramer; Marjolein Reinders; Hans Blokzijl; Roelof van der Meer; Jaap Keijer
Journal:  Genes Nutr       Date:  2007-10-16       Impact factor: 5.523

Review 9.  Pentraxins and Fc receptors.

Authors:  Jinghua Lu; Kristopher D Marjon; Carolyn Mold; Terry W Du Clos; Peter D Sun
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

Review 10.  Pentraxins, anti-pentraxin antibodies, and atherosclerosis.

Authors:  N Bassi; S Zampieri; A Ghirardello; M Tonon; M Zen; F Cozzi; A Doria
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.